United States: AdvaMed's Updated Code Of Ethics

The Advanced Medical Technology Association (AdvaMed) has published its updated Code of Ethics. The updated code will become effective on January 1, 2020. AdvaMed has also published an overview of changes.

The updated AdvaMed Code now includes "Key Concepts" at the beginning of each section, with visuals, graphics, callout boxes, examples, explanations and FAQs.

The AdvaMed Code provides medical technology companies with guidance on ethical interactions and relationships with healthcare professionals (HCPs) to ensure that medical decisions are based on the best interests of the patient.

Because the medical technology industry is highly divergent, the AdvaMed Code drafters recognize no single compliance program fits each company. Therefore, AdvaMed encourages companies to adopt an "appropriately tailored" ethics and compliance program, accounting for the specific types of risks that apply to their operations. Companies adopting the AdvaMed Code are encouraged to submit to AdvaMed an annual certification stating adoption of the AdvaMed Code and implementation an effective compliance program.

The updated "Consulting Arrangements with Health Care Professionals" section states that all consulting arrangements with HCPs should be based on certain principles including hiring consultants only when there is a legitimate need; selecting only duly vetted HCP consultants; providing fair market value compensation; reimbursing only documented, reasonable and actual expenses; having written agreements; and not allowing sales personnel to have control or undue influence over hiring a specific HCP.

"Legitimate need" arises when a company requires the services of an HCP to achieve a specific objective. Designing or creating an arrangement to generate business or referrals are not legitimate needs.

The AdvaMed Code further provides suggestions on establishing a "fair market value" for consulting arrangements and encourages companies to document such methodology.

The AdvaMed Code states that companies should be aware that interactions with other companies may potentially create conflicts of interest for HCPs and recommends companies take steps to address the conflicts, including, for example, recusal from decisions that may implicate the conflict.

The AdvaMed Code now consolidates company-conducted training and education and other business meetings into a single section about company-conducted programs. Likewise, the AdvaMed Code merges existing sections on providing support for third-party educational, charitable and research programs into one section on grants, donations and commercial sponsorships.

The educational grants section now provides a checklist of review questions for use in evaluating requests.

The AdvaMed Code prohibits companies from providing monetary or in-kind contribution directly to an individual HCP. However, Satellite Symposia are permitted under the AdvaMed Code, and companies may pay for travel, lodging or registration expenses of an HCP when the HCP serves as a bona fide faculty member at a Satellite Symposium.

The AdvaMed code expands and clarifies requirements for supporting independent research grant requests, and provides parameters for providing charitable donations.

In the section "Jointly Conducted Education and Marketing Programs," the AdvaMed Code provides that a company may partner with an HCP to conduct joint education and marketing programs designed to highlight both medical technology and the HCP's ability to diagnose or treat a medical condition, provided that the company and the HCP serve as bona fide partners. Contribution costs should be shared equitably between the parties. Other limitations include a legitimate need to engage the HCP and a written agreement detailing purpose of the arrangement, the roles, responsibilities and contributions of each party.

The "Travel & Lodging; Venue" section consolidates existing travel guidance and provides that a company may pay for modest and reasonable travel and lodging costs to attend a company-conducted program or meeting under certain circumstances. The AdvaMed Code provides clarification on when travel is permitted (e.g., for consulting or training when legitimate need for meeting) and prohibited (e.g., for general education not concerning a medical technology or when there is no legitimate need). This section provides guidance for choosing a setting/venue (e.g., central location, conducive to exchange of information, limits on top category or luxury hotels).

The "Providing Modest Meals and Refreshments to Health Care Professionals" section consolidates guidance on meals and states that meals and refreshments should be provided to HCPs in a manner and place conducive to the presentation of scientific, educational or business information. Meals and refreshments should be subordinate in time and in focus to the discussion and presentation of such information. The AdvaMed Code encourages companies to develop policies on providing modest and occasional meals to HCPs. The policies may establish a per meal spending limit with a HCP and whether the amount should vary to account for geographic areas (for example, New York City) that are generally more expensive.

The "Educational & Patient Benefit Items; Prohibition on Gifts" section provides that companies may not provide branded, promotional items or gifts to HCPs. Instead, companies may provide HCPs with modest educational items, such as medical textbooks, anatomical models or any educational item having a fair market value of less than $100 or patient benefit items, such as starter kits and educational brochures. The AdvaMed Code states that companies may not provide entertainment or recreation to HCPs in any form.

The AdvaMed Code adds a new section on "Communicating for the Safe & Effective Use of Medical Technology," which provides principles for communicating on unapproved/uncleared uses. As stated therein, "Access to truthful and non-misleading information relating to Medical Technologies... is critical to a Health Care Professional's ability to exercise his or her medical judgment... to provide high-quality care, and to safely use available Medical Technology." Accordingly, company responses that contain information regarding unapproved or uncleared uses should be provided by personnel with clinical expertise in the unapproved/uncleared use, not sales personnel. The AdvaMed Code provides examples of communication activities under which companies may disseminate information to healthcare professionals. However, information related to unapproved or uncleared uses should be identified as such. The AdvaMed Code encourages companies to apply the principles and develop related controls for appropriately disseminating such information.

A final new section, "Company Representatives Providing Technical Support in the Clinical Setting," provides that company representatives may play an important role in the clinical setting by providing technical support on the safe and effective use of medical technology, including providing explanations as to functionality and use and assisting the clinical/operating room team with respect to the appropriate range of devices and accessories available during a procedure. The AdvaMed Code, however, places limitations on such assistance: (1) company representatives may enter and be present in the clinical setting only at the request of and under the supervision of a HCP; (2) company representatives should be transparent that they are acting on behalf of the company in a technical support capacity; (3) company representatives should not interfere with an HCP's clinical decision making; (4) company representatives should comply with applicable hospital or facility policies and requirements; and (5) the company's technical support should not eliminate an expense that the HCP would otherwise incur while providing patient care.

The AdvaMed Code will become effective on January 1, 2020.

For More Information

If you have any questions about this Alert, please contact Frederick R. Ball, Jonathan Lourie, any of the attorneys in our Life Sciences Industry Group or the attorney in the firm with whom you are regularly in contact.

Disclaimer: This Alert has been prepared and published for informational purposes only and is not offered, nor should be construed, as legal advice. For more information, please see the firm's full disclaimer.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions